Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BHST
12251
BioHarvest Sciences
BHST
$33.3M
| $64K | ﹤0.01% |
14,753
-614
| -4% | -$2.89K |
2025 Q4
1 quarter
|
|
|
KNDI
12252
Kandi Technologies Group
KNDI
$82.4M
| $63.9K | ﹤0.01% |
76,526
-92,080
| -55% | -$89.7K |
2021 Q1
20 quarters
|
|
|
TOKE
12253
CALL
DELISTED
Cambria Cannabis ETF
TOKE
| $63.9K | ﹤0.01% |
+12,500
| New | +$71.5K |
2026 Q1
0 quarters
|
|
12254
PUT
iHeartMedia
IHRT
$300M
| $63.7K | ﹤0.01% |
+21,800
| New | +$72.2K |
2026 Q1
0 quarters
|
|
12255
BioVie
BIVI
$12.7M
| $63.4K | ﹤0.01% |
45,292
+27,142
| +150% | +$34.9K |
2025 Q3
2 quarters
|
|
|
NXDR
12256
CALL
Nextdoor Holdings
NXDR
$944M
| $63.1K | ﹤0.01% |
45,100
-156,600
| -78% | -$272K |
2025 Q3
2 quarters
|
|
12257
PUT
Rekor Systems
REKR
$51.1M
| $63K | ﹤0.01% |
76,800
-85,200
| -53% | -$91.2K |
2020 Q4
21 quarters
|
|
12258
PUT
Five Point Holdings
FPH
$326M
| $62.9K | ﹤0.01% |
+13,000
| New | +$69.8K |
2026 Q1
0 quarters
|
|
|
BLDP
12259
PUT
Ballard Power Systems
BLDP
$720M
| $62.7K | ﹤0.01% |
25,900
-24,900
| -49% | -$59.4K |
2019 Q1
28 quarters
|
|
|
GSOL
12260
CALL
Grayscale Solana Staking ETF
GSOL
$155M
| $62.5K | ﹤0.01% |
+10,200
| New | +$76.8K |
2026 Q1
0 quarters
|
|
12261
CALL
Spero Therapeutics
SPRO
$69.3M
| $62.5K | ﹤0.01% |
+26,700
| New | +$63.4K |
2026 Q1
0 quarters
|
|
12262
PUT
Equillium
EQ
$89.4M
| $62.4K | ﹤0.01% |
31,200
-48,400
| -61% | -$79.6K |
2025 Q4
1 quarter
|
|
12263
Mastech Digital
MHH
$85.9M
| $62.4K | ﹤0.01% |
+10,959
| New | +$72.3K |
2026 Q1
0 quarters
|
|
12264
CALL
Spruce Power Holding Corp
SPRU
$30.4M
| $62.3K | ﹤0.01% |
15,200
-4,300
| -22% | -$19.9K |
2025 Q3
2 quarters
|
|
|
AGNT
12265
PUT
AGNT Inc
AGNT
$610M
| $62.3K | ﹤0.01% |
10,400
-27,400
| -72% | -$212K |
2020 Q3
22 quarters
|
|
12266
Nephros
NEPH
$39.9M
| $62.2K | ﹤0.01% |
20,888
+178
| +0.9% | +$711 |
2024 Q2
7 quarters
|
|
12267
CALL
Xeris Biopharma Holdings
XERS
$1.66B
| $62.1K | ﹤0.01% |
10,700
+500
| +5% | +$3.31K |
2025 Q4
1 quarter
|
|
12268
PUT
Lexicon Pharmaceuticals
LXRX
$810M
| $61.9K | ﹤0.01% |
39,700
-45,600
| -53% | -$66.3K |
2022 Q4
13 quarters
|
|
|
SMUP
12269
CALL
T-REX 2X Long SMR Daily Target ETF
SMUP
$4.68M
| $61.9K | ﹤0.01% |
+5,952
| New | +$148K |
2026 Q1
0 quarters
|
|
|
VIVO
12270
CALL
VivoPower PLC
VIVO
$107M
| $61.9K | ﹤0.01% |
26,900
-18,200
| -40% | -$40.6K |
2025 Q3
2 quarters
|
|
12271
CALL
Universal Electronics
UEIC
$73.1M
| $61.8K | ﹤0.01% |
+15,000
| New | +$59.6K |
2026 Q1
0 quarters
|
|
|
MTLS
12272
CALL
Materialise
MTLS
$490M
| $61.8K | ﹤0.01% |
+12,500
| New | +$67.4K |
2026 Q1
0 quarters
|
|
|
FOFO
12273
Hang Feng Technology Innovation Co
FOFO
$16.5M
| $61.7K | ﹤0.01% |
+14,617
| New | +$72.8K |
2026 Q1
0 quarters
|
|
12274
IRIDEX
IRIX
$11.3M
| $61.5K | ﹤0.01% |
60,851
+26,456
| +77% | +$36.1K |
2022 Q4
13 quarters
|
|
12275
CALL
Lexeo Therapeutics
LXEO
$290M
| $61.4K | ﹤0.01% |
+10,700
| New | +$75.8K |
2026 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.